Program at-a-Glance


Time

Day 1

Day 2

Day 3

Day 4

Sunday
February 8

Monday
February 9

Tuesday
February 10

Wednesday
February 11

8:30-9 am

Program Committee Workshop for New Investigators and Trainees

 

Plenary

Prospects for Better Control of HIV/TB:  From the Clinic to the Community
Elizabeth Corbett
London Sch of Hygiene and Tropical Med, UK and Biomed Res and Training Inst, Harare, Zimbabwe

Plenary

Pre-Exposure Prophylaxis: Could It Work?
Sharon Hillier
Magee-Women’s Res Inst, Univ of Pittsburgh, PA, US

Plenary

Prevention of Breast-feeding Transmission
Jeffrey Stringer
Univ of Alabama at Birmingham, US and Ctr for Infectious Disease Res, Lusaka, Zambia

9-9:30 am

Plenary

Immune Effects at HIV-infected Mucosal Surfaces
 Daniel Douek
Vaccine Res Ctr, NIAID, NIH, Bethesday, MD, US

Plenary

Cellular Co-factors of HIV Integrase—from Target Identification to Drug Discovery 
Zeger Debyser
Katholieke Univ Leuven, Belgium

Plenary

Local Origin and Global Spread of Immunodeficiency Viruses
Michael Worobey
Univ of Arizona, Tucson, US

9:30-10 am

Break

Break

Break

10 am-12 n

Genomics Workshop

Oral Abstract Sessions

Virus Biology: Insights into Evolution, Replication, and Restriction

Prevention and Treatment of Serious OIs and Malignancies

Pharmacogenetics, Pharmacoenhancement, and Complications of ART

HIV Transmission: Characteristics and Prevention

Oral Abstract Sessions

HIV-Host Interaction

Recent Developments in Vaccines and Immune-based Therapies

Critical Health Issues in Mothers, Infants, and Children

Interplay among Treatment, Immune Responses, and Outcomes in Hepatitis Virus Co-infections

Oral Abstract Sessions

Late Breaking Insights into HIV Virology

HIV Testing and ART in Resource-constrained Settings

Pathogenesis of HIV Complications

Emerging  Patterns of Neuropathogenesis on Current ART


12-12:30 pm

 

Lunch

Lunch

Lunch

12:30-1 pm

Luncheon:
HIV Science from the Perspective of a Journalist
(for young investigator, intl scholar, & comm ed awardees)

1-1:30 pm

Poster Abstract Sessions

Poster Abstract Sessions

Poster Abstract Sessions

1:30-2 pm

         

2-2:30 pm

Opening Symposium

The Global Epidemic

2:30-3:30 pm

Themed Discussions

Themed Discussions

Themed Discussions

3:30-4 pm

Break

Break

Break

4-6 pm

Opening Plenary Session

14 th Bernard Fields Lecture
Robert Siliciano
Johns Hopkins Univ,
Baltimore , MD , US

Musical Performance
Oliver Mtukudzi
musician activist, Zimbabwe

3 rd N’Galy-Mann Lecture
Glenda Gray and
James McIntyre
Univ of the Witwatersrand,
Chris Hani Baragwanath Hosp, Johannesburg, South Africa

Symposia

Clues to Lentiviral Pathogenesis

A Tale of 4 Cities

Advances in Therapy of
Hepatitis Viruses

Oral Abstract Session

Mechanisms of Drug Resistance and Optimal Timing of ART

Symposia

Retroviruses and Their Hosts through the Millennia

Learning from Negative Trials

HIV Drug Resistance and Treatment Response 

Oral Abstract Session

Mechanisms of Immunologic Control of HIV/SIV Infection

Symposia

Vaccine—Back to Basics

Insights into HIV
Replication from Analysis
of Single Molecules

Long-term Non-AIDS Complications

Oral Abstract Session

HIV Transmission, Treatment Initiation, and Women's Health Issues

6-8 pm

Welcome Reception

 

Time

Monday, February 9

Tuesday, February 10

Wednesday, February 11

7 am-7 pm

Poster Halls open 7 am to 7 pm Monday through Wednesday
All posters will be available for viewing for the duration of the conference

1-2:30 pm

Poster Sessions


Viral Replication Cycle

Viral Tropism, Entry, and  Transmission

Cellular Factors Affecting Viral Replication and Pathogenicity

Molecular Characterization of Viral Epidemics

Molecular Epidemiology of HIV
Transmission and Distribution

Molecular Epidemiology: Zoonoses, Recombination, and Co-infection

New Insights into T Cell Activation and Turnover

Scientific Discoveries in CD4 T Cell Function

TH17 and Treg: The Other CD4 T Cells

What's New in Mucosal Immunity

Improvements in Immune Assays

Viral and Host Factors in Immunopathogenesis

Gut Pathogenesis and Mucosal Defenses

Mechanisms of Neuropathogenesis

Genome-wide Studies of HIV Control and Disease Progression
  < also a Themed Discussion on Tuesday>

Is Duffy Antigen Associated with Outcome of HIV Infection?

Inhibitors of HIV Entry and Integration
 
HIV RT, RNase H, Protease, and Maturation Inhibitors

Novel HIV Inhibition Approaches: Vpu, RNAi, and Rapamycin

Anti-HIV Activity of Acyclovir: Back to the Future

New ARVs, including Pharmacokinetics in Healthy Volunteers

ART: Randomized Trials

Resistance to Integrase Inhibitors

Biochemical Mechanisms of RTI Resistance

Gag Mutations and Drug Resistance

Resistance to Inhibitors of HIV-1 Entry

Morbidity and Mortality: Non-AIDS Events

Alterations in Blood Lipids and Body Fat

Immune Responses to TB

Immunologic Mechanisms and Clinical Features of IRIS
  < also a Themed Discussion on Tuesday>

Epidemiology of Hepatitis Co-infection

Responses to HBV Vaccination

HBV Virology and Outcomes

HBV: Response to Therapy and Drug Resistance

Studies of Cancer Incidence

Viral Pathogenesis, Treatment, and Outcome of KSHV-associated Diseases

HIV-associated Cervical and Anal Cancers

Risk Factors, Prevalence, and Prognosis of HIV-associated Lymphomas

Integrase Inhibitor Therapy in Children

Response to ART in Children in Resource-constrained Settings

Pharmacokinetics in Children

Resistance after First-line Failure in Children

ART Pharmacokinetics during Pregnancy and Infancy

Complications of ART during Pregnancy and Delivery

Outcomes of Prenatal NRTI Exposure

Detecting Acute/Incident Infection

Rapid Tests for HIV Diagnosis

Recent Discoveries in HIV Transmission

Recent Discoveries in the Epidemiology of HIV Disease Progression

Host-cell Restriction Factors
  < also a Themed Discussion on Wednesday>

Viral Accessory Proteins and Cellular Restrictions

New Insights into B Cells

Recent Discoveries on Neutralizing Antibodies

New Insights into the Mechanisms of Elite Control
  < also a Themed Discussion on Wednesday>

Immune and Virologic Markers of HIV Elite Control

Host and Viral Contributions to HIV Disease

Compartments of HIV Infection

HIV Latency and Reservoirs

Latency, Reservoirs, and Impact of Treatment Intensification
  < also a Themed Discussion on Monday>

Aging and Metabolic Syndromes as Risk Factors for Neurologic Disorders 
  < also a Themed Discussion on Monday>

HCV and OIs in NeuroAIDS

Viral Infection of CNS Compartments

Viral Genetics of HIV-1 Transmission

Natural History of HIV Transmission

Vaccines to Prevent Infection or Alter Disease Progression

ART: Observational Studies

Delivery of Care in Resource-constrained Settings

Circulating Drug Resistance in HIV-infected Populations

Transmission of Drug-resistant HIV

Use of Novel Technologies to Understand HIV Drug Resistance
  < also a Themed Discussion on Wednesday>

Resistance Assays and Their Interpretation

Subclinical Atherosclerosis and Cardiovascular Events: Role of HIV and ART

Inflammatory Markers, ART, and Complications

TB Diagnostics

Drug Resistant TB: Diagnosis and Outcomes

Immunologic Outcomes of HCV Co-infection

Determinants of HCV Treatment Outcomes

Influence of ART on HCV Co-infection

HCV Virology and Impact of ART Interruption

Viral and Host Factors Associated with Pediatric Disease

Immune Response to HIV and Protective Vaccines in Children

Longitudinal Outcomes in Perinatally Infected Children

Adolescent HIV Epidemic in Africa

Screening and Barriers to Care for HIV-infected Adolescents

Trends in MTCT in the US

Risk Factors for MTCT

Viral and Host Factors Associated with MTCT

Genital HIV Shedding
  < also a Themed Discussion on Monday>

Cervical Disease

Metabolic and Hormonal Abnormalities

Effect of PMTCT Interventions on Maternal Outcomes

ART Toxicity and Outcomes

Methods of Viral Load Monitoring

Use of Dried Blood for HIV Viral Load Monitoring

STI Screening and Effect of ART

HSV-2/HIV-1 Interactions

Incident and Endemic Syphilis

Acceptance and Influence of Male Circumcision

Novel Microbicide Gels and Rings 
  < also a Themed Discussion on Wednesday>

Prevention Strategies: Pre- and Post-exposure Prophylaxis

Regulation of Viral Latency

Viral Reservoirs: Monocyte/Macrophage Studies

Modulation of HIV by other Viruses

The Expanding Role of Natural Killer Cells in HIV Infection

New Discoveries in Antigen-presenting Cells and HIV

Characterization of CD8 T Cell Function

Mechanisms of CD8 T Cell Dysfunction

TCR, MHC, and Viral Recognition or Escape

Dynamics of HIV/SIV Infection

Evolution of Tropism in HIV-infected Patients

HIV Evolution in vivo

Clinical Studies and Therapy of CNS Infection

Mucosal Infection

Models for Prevention of HIV Transmission and Disease

Novel Immune-based Therapies

Immune Therapies Involving Interleukin-2

New Therapeutic Vaccines and Strategies

Outcomes on ART in Resource-constrained Settings: Randomized Trials and Observational Cohorts

Second-line Therapy in Resource-constrained Settings
  < also a Themed Discussion on Monday>

Generic ARVs in Resource-constrained Settings

Evolution of RT and PI Resistance in Patients

Drug Resistance and Viral Fitness

Outcomes of HIV Drug Resistance

Pharmacokinetics and Pharmacogenetics of ARVs

ARV Drug-Drug Interactions

Sanctuary Sites and Intracellular Pharmacokinetics of ARVs 
  < also a Themed Discussion on Tuesday>

Renal Dysfunction: Role of HIV and ART

Non-viral Hepatic Complications: HIV and ART Effects

Osteopenia and Osteoporosis

Anemia and Lactic Acidosis

TB Risk and Treatment Outcomes

Cryptococcal Infection: Diagnosis and Treatment

Viral OIs

Hepatitis Delta Virus Co-infection

Complications of Hepatitis Co-infection

Non-invasive Assessment of Liver Fibrosis

Liver Fibrosis in Hepatitis Co-infection

Outcomes of Liver Transplantation

Prevention of TB and Treatment of HIV and TB in Children
  < also a Themed Discussion on Tuesday>

Complications, Toxicities, and Neurodevelopment in Children

HIV-related Complications in Children in Resource-constrained Settings

Resistance and Clinical Outcomes after Single-dose Nevirapine for PMTCT

Properties of Breast Milk and MTCT

Infant Feeding and Infant Outcomes

Diagnosing HIV Exposure in Infants

Comparison of HIV Tropism Assays

Novel Diagnostic Assays

New Insights into Groups at Risk

New Insights from Incidence and Prevalence Testing

HIV Testing in Resource-constrained Settings

2:30-3:30 pm

Themed Discussions


Genital HIV Shedding

Aging and Metabolic Syndromes as Risk Factors for Neurologic Disorders

Latency, Reservoirs, and Effect of Treatment Intensification

Second-line Therapy in Resource-constrained Settings
Sanctuary Sites and Intracellular Pharmacokinetics of ARV

Genomic-wide Studies of HIV Control and Disease Progression

Prevention of TB and Treatment of HIV and TB in Children

Immunologic Mechanisms and Clinical Features of IRIS
Host-cell Restriction Factors 

New Insights into the Mechanisms of Elite Control

Novel Microbicide Gels and Rings

Use of Novel Technologies to Understand HIV Drug Resistance